Targeting mitochondrial reactive oxygen species to modulate hypoxia-induced pulmonary hypertension.
about
Mitochondria in lung diseaseHypoxia-induced pulmonary hypertension in type 2 diabetic mice.Constitutive Reprogramming of Fibroblast Mitochondrial Metabolism in Pulmonary Hypertension.Physiological redox signalling and regulation of ion channels: implications for pulmonary hypertension.NADPH oxidase: its potential role in promotion of pulmonary arterial hypertension.Mitochondrial catalase overexpressed transgenic mice are protected against lung fibrosis in part via preventing alveolar epithelial cell mitochondrial DNA damage.Thin Air Resulting in High Pressure: Mountain Sickness and Hypoxia-Induced Pulmonary Hypertension.Reactive Oxygen and Nitrogen Species in the Development of Pulmonary Hypertension.Contribution of reactive oxygen species to the pathogenesis of pulmonary arterial hypertensionNADPH oxidase 4 is not involved in hypoxia-induced pulmonary hypertension.From Physiological Redox Signalling to Oxidant Stress.Altered Redox Balance in the Development of Chronic Hypoxia-induced Pulmonary Hypertension.Hypoxia inhibits expression and function of mitochondrial thioredoxin 2 to promote pulmonary hypertension.NADPH oxidase-2 mediates zinc deficiency-induced oxidative stress and kidney damage.Reactive oxygen species effect PASMCs apoptosis via regulation of dynamin-related protein 1 in hypoxic pulmonary hypertension.Metabolic Reprogramming and Redox Signaling in Pulmonary Hypertension.Hypoxia Selectively Upregulates Cation Channels and Increases Cytosolic [Ca2+] in Pulmonary, but not Coronary, Arterial Smooth Muscle Cells.Domain Mapping of Heat Shock Protein 70 Reveals That Glutamic Acid 446 and Arginine 447 Are Critical for Regulating Superoxide Dismutase 2 Function.The mitochondrial-targeted peptide, SS-31, improves glomerular architecture in mice of advanced age.Recurrent inhibition of mitochondrial complex III induces chronic pulmonary vasoconstriction and glycolytic switch in the rat lung.NOX4 expression and distal arteriolar remodeling correlate with pulmonary hypertension in COPD.EXPRESS: Hypoxia-induced pulmonary vasoconstriction of intra-acinar arteries is impaired in NADPH oxidase 4 gene-deficient mice
P2860
Q28387993-88D82AC7-3DDC-4BF3-B82E-3C0F490AB9D1Q33738536-907444DF-FC5D-4E4B-9EF2-DFF4423851F6Q37088266-6A6A7EA4-6E3A-4019-935D-87BFBA97A9EAQ39048721-78676F09-C838-4EF8-B0EE-87C1A14FDEAFQ39132107-1039C6FE-36B3-4813-BC65-679B4F929A75Q39191013-1CEEEDAF-318A-4D01-95D5-DB2DB2806762Q39316798-0FC6EE14-56C0-4153-954F-EC95F3504247Q39419466-8D4852A5-85AA-40B2-8292-7F3F18521346Q40987019-38B1B9E5-7B08-432C-8C95-08A8F3C61D94Q41065375-6CD4E82A-1E40-4151-A627-FBBA45FB1C95Q46280819-7D24171C-A5EB-473E-84CA-FADEDE09FCD0Q46280877-61AA797B-2ECA-4EE7-B9A6-210A3D01A52AQ46426649-03B69331-F33C-45C7-A396-9F02139990F0Q46465429-8B063BD1-E381-4164-BAF5-4EEDE62739DDQ46574326-1B058FEE-47D6-4D4F-9D2E-FE0B8D99F058Q47631019-507774D5-375E-4E22-8FDD-22D0A373D8D1Q47652578-EBB3A28F-44DD-4AA2-88E1-F04292C63556Q49814595-A7DD4DF9-90BA-43DC-9279-ECA2B5007701Q51210259-1B9DA25A-C887-43D1-BEF5-5B09EE83DDC7Q52312349-28134645-9BF6-4CC4-B078-8DC83E06BB35Q55648659-01F95D7C-E574-4734-B25A-F0E6A27E71CDQ57031650-CAAC0AC5-A2E9-4EB9-8373-08BEDE762935
P2860
Targeting mitochondrial reactive oxygen species to modulate hypoxia-induced pulmonary hypertension.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Targeting mitochondrial reacti ...... nduced pulmonary hypertension.
@en
Targeting mitochondrial reacti ...... nduced pulmonary hypertension.
@nl
type
label
Targeting mitochondrial reacti ...... nduced pulmonary hypertension.
@en
Targeting mitochondrial reacti ...... nduced pulmonary hypertension.
@nl
prefLabel
Targeting mitochondrial reacti ...... nduced pulmonary hypertension.
@en
Targeting mitochondrial reacti ...... nduced pulmonary hypertension.
@nl
P2093
P2860
P1476
Targeting mitochondrial reacti ...... nduced pulmonary hypertension.
@en
P2093
Bum-Yong Kang
C Michael Hart
Juan Cheng
Kaiser M Bijli
Roy L Sutliff
Sherry E Adesina
Tamara C Murphy
P2860
P356
10.1016/J.FREERADBIOMED.2015.05.042
P577
2015-06-11T00:00:00Z